Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)

Key Terms

cash dividend financial

A cash dividend is a payment made by a company to its shareholders directly in money, usually on a regular schedule. It is a way for investors to receive a portion of the company's profits, similar to earning interest or a bonus for holding the company's stock. Cash dividends provide income to shareholders and can indicate the company's financial health and stability.

biopharmaceutical medical

A biopharmaceutical is a medicine made from living organisms or their components—such as proteins, cells or genetic material—rather than chemically synthesized compounds. For investors, these products can command high prices and long patent protection but also carry bigger development, manufacturing and regulatory risks; think of them like handcrafted, high-tech products that can generate strong returns if they work, but are costly and complex to produce.

03/12/2026 - 04:30 PM

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895.

Separately, the Company also announced today that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), has been elected to Colgate-Palmolive's Board of Directors effective March 15, 2026.

Dr. Boerner, 55, has served as Chief Executive Officer of Bristol Myers Squibb, a global biopharmaceutical company, since November 2023 and as Board Chair since April 2024 and will bring extensive global business leadership experience and expertise in the pharmaceutical and healthcare industries, complementary industries, to Colgate-Palmolive’s Board. He previously served as Executive Vice President, Chief Operating Officer of Bristol Myers Squibb in 2023 and as Executive Vice President, Chief Commercialization Officer from 2018 to 2023. Prior to those roles, he served as Head of International Markets and Head of U.S. Commercial Markets after joining Bristol Myers Squibb in 2015.

The Company also announced that Steven A. Cahillane advised the Board that he will not stand for reelection to the Board at the Annual Meeting of Stockholders to be held on May 8, 2026.

Commenting on the new director election, Noel Wallace, Colgate-Palmolive’s Chairman, President and CEO, said, “We warmly welcome Chris to the Board and look forward to the contributions his exceptional capabilities will bring to our company. We express our deepest gratitude to Steve for his dedicated service and invaluable impact on Colgate-Palmolive's success, and we wish him every success going forward.”

* * *

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-C